2008 News Releases
November 1, 2008 - Kinexus adds a Kinase Inhibitor Compound Profiling Service (KICP) to its service portfolio.
This new service is designed to assist researchers in ascertaining the specificity of lead compounds and their mechanisms of action for the selection of better drug candidates for clinical testing.
This new service is designed to assist researchers in ascertaining the specificity of lead compounds and their mechanisms of action for the selection of better drug candidates for clinical testing.